Skip to main content

Galante Joseph C's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Nov 18, 2022

Accession no.
0001209191-22-057942
Filed
Nov 18, 2022
Trade date
Sep 27-Oct 31, 2022
Filing delay
52 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 25 non-derivative transactions and 0 derivative transactions. Open-market purchases total $4.05K. It was filed 52 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Galante Joseph CCIK 0001632384Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 27, 2022Common StockPPurchaseAcquired+65$2.57+$167.0552,881Direct
Sep 28, 2022Common StockPPurchaseAcquired+65$2.52+$163.852,946Direct
Sep 29, 2022Common StockPPurchaseAcquired+65$2.51+$163.1553,011Direct
Sep 30, 2022Common StockPPurchaseAcquired+65$2.61+$169.6553,076Direct
Oct 3, 2022Common StockPPurchaseAcquired+65$2.54+$165.153,141Direct
Oct 4, 2022Common StockPPurchaseAcquired+65$2.61+$169.6553,206Direct
Oct 5, 2022Common StockPPurchaseAcquired+65$2.58+$167.753,271Direct
Oct 6, 2022Common StockPPurchaseAcquired+65$2.65+$172.2553,336Direct
Oct 7, 2022Common StockPPurchaseAcquired+65$2.66+$172.953,401Direct
Oct 10, 2022Common StockPPurchaseAcquired+65$2.53+$164.4553,466Direct
Oct 11, 2022Common StockPPurchaseAcquired+65$2.48+$161.253,531Direct
Oct 12, 2022Common StockPPurchaseAcquired+65$2.49+$161.8553,596Direct
Oct 13, 2022Common StockPPurchaseAcquired+65$2.38+$154.753,661Direct
Oct 14, 2022Common StockPPurchaseAcquired+65$2.31+$150.1553,726Direct
Oct 17, 2022Common StockPPurchaseAcquired+65$2.33+$151.4553,791Direct
Oct 18, 2022Common StockPPurchaseAcquired+65$2.46+$159.953,856Direct
Oct 19, 2022Common StockPPurchaseAcquired+65$2.42+$157.353,921Direct
Oct 20, 2022Common StockPPurchaseAcquired+65$2.44+$158.653,986Direct
Oct 21, 2022Common StockPPurchaseAcquired+65$2.49+$161.8554,051Direct
Oct 24, 2022Common StockPPurchaseAcquired+65$2.38+$154.754,116Direct
Oct 25, 2022Common StockPPurchaseAcquired+65$2.44+$158.654,181Direct
Oct 26, 2022Common StockPPurchaseAcquired+65$2.42+$157.354,246Direct
Oct 27, 2022Common StockPPurchaseAcquired+65$2.49+$161.8554,311Direct
Oct 28, 2022Common StockPPurchaseAcquired+65$2.52+$163.854,376Direct
Oct 31, 2022Common StockPPurchaseAcquired+65$2.54+$165.154,441Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)